OOIR: Observatory of International Research

Papers

(The H4-Index of SLAS Discovery is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models	105
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei	69
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay	54
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies	45
Bioassay protocol metadata annotation: Proposed standards adoption	43
Outline and background for the EU-OS solubility prediction challenge	42
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening	37
Protocol for 3D screening of lung cancer spheroids using natural products	36
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery	31
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature	30
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection	30
Ex vivo discovery of synergistic drug combinations for hematologic malignancies	28
Emerging drug discovery ecosystems	27
An efficient and scalable data analysis solution for automated electrophysiology platforms	26
Drug repurposing screen for the rare disease ataxia-telangiectasia	24
Parallel in vitro ion channel and in vivo zebrafish assaying of elapid snake venoms following chromatographic separation of toxin components	23
The Impact of Assay Design on Medicinal Chemistry: Case Studies	22
Automation of Organoid Cultures: Current Protocols and Applications	21
Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease	21
Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells	21
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening	21